Latest News
-
HBS Reporting
Heart inflammation risk boosted slightly by vaccine, more by COVID-19 – study
Aug 26, 2021(Reuters) – The use of Pfizer Inc and German partner BioNTech SE’s widely used COVID-19 vaccine...
-
HBS Reporting
Britons turn critical of government’s pandemic response
Aug 26, 2021LONDON, Aug 26 (Reuters) – The British public’s view of the government’s management of the coronavirus...
-
HBS Reporting
Novartis’s Kymriah does not meet primary endpoint in phase III study
Aug 24, 2021ZURICH, Aug 24 (Reuters) – Novartis ag (NOVN.S) said its Kymriah to treat aggressive B-cell non-Hodgkin...
-
HBS Reporting
Israel’s COVID-19 vaccine boosters show signs of taming Delta
Aug 24, 2021JERUSALEM (Reuters) – Less than a month into a COVID-19 vaccine booster drive, Israel is seeing...
-
HBS Reporting
What you need to know about the coronavirus right now
Aug 24, 2021Aug 24 (Reuters) Here’s what you need to know about the coronavirus right now: Australia pandemic...
-
HBS Reporting
Amid COVID surge, some Sri Lankans opt for cardboard coffins when cremating loved ones
Aug 24, 2021COLOMBO (Reuters) – At a factory in Sri Lanka’s Dehiwala-Mount Lavinia city, workers use staples and...
-
HBS Reporting
New Zealand has highest jump in COVID-19 cases since April 2020
Aug 24, 2021WELLINGTON, Aug 24 (Reuters) – New Zealand on Tuesday recorded its highest increase in COVID-19 cases...
-
HBS Reporting
Six U.S. states do not join $26 bln opioid settlements with distributors, J&J
Aug 24, 2021Aug 23 (Reuters) – At least six U.S. states, including Georgia, did not fully sign on...
-
HBS Reporting
Researchers seek powerful antibody against many variants; breakthrough cases may be less infectious
Aug 24, 2021Aug 23 (Reuters) – Here is a summary of some recent studies on COVID-19. They include...
-
HBS Reporting
FDA approves Cara’s drug for severe itching in kidney disease patients
Aug 24, 2021Aug 23 (Reuters) – The Food and Drug Administration on Monday approved Cara Therapeutics’s (CARA.O) drug...